The opinion
The opinion of the court was delivered by
Parker, J.
The bill claimed that a medicinal preparation manufactured and distributed by complainant and called “Duke’s Magnesia Citro-Tartrate” was a proprietary medicine within the excepting language of section 9 of the “Pharmacy act”
(Comp. Stat. pp. 3943, 3946)
and so not within the prohibitory language of section 3 of that act; and prayed that the board of pharmacy, its agents, etc., be restrained “from interfering with the business of complainant in the sale of said Duke’s Magnesia Citro-Tartrate, and from stating or representing to any customers or prospective customers of complainant, or to the wholesale or retail grocery trade that the sale or resale of said Duke’s Magnesia Citro-Tartrate is in any way contrary to law, or that the sale at retail thereof involves any breach of law or that any dealers are properly subject to prosecution by virtue of anjr such resale.”
The vice-chancellor on final hearing held that the product in question was merely common citrate of magnesia, a recognized drug preparation, “slightly adulterated and of slightly less potent character,” and hence within the prohibitions of section 3. Accordingly he vacated the preliminary injunction and dismissed the bill.
We think that on the evidence the above finding of fact is manifestly right; and accordingly the decree will be affirmed.
The question whether the court of chancery had jurisdiction to entertain the bill and award an injunction in a case of this character, was not raised below, and we express no opinion thereon at this time.
For affirmance
— The Chief-Justice, Trenchard, Parker, Case, Bodine, Heiier, Perskie, Heteield, Dear, Wells, WolesKeil, Raeeerty, Cole, JJ. 13.
For reversal
— None.